BlogTalkRadio uses cookies. By using our services, you're agreeing to our Cookies Policy. Got it

Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

PD1 Resistance with a Multi-Omic Approach

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio

×  

Follow This Show

If you liked this show, you should follow Pharma Talk Radio.
h:548881
s:11690764
archived

Anti-PD-1 therapy has transformed cancer care but most patients do not respond. It is increasingly clear that there will be no single biomarker of response to a PD-1, and that a multi-omic approach will be required. In this podcast, first recorded at the 4th annual IO Combinations 360° conference, Dr Danny Wells, Parker Institute for Cancer Immunotherapy will address:

  • Orthogonality and correlation of response biomarkers across histologies
  • Integration of multi-omic data sets for mechanistic insights into tumor immunobiology
  • The translational approaches to PD1 resistance program at the Parker Institute

To learn more about the upcoming IO Combinations 360° conference please visit, www.iocombinations360.com

Comments